Magnetic Nanoparticles Enhance Adenovirus Transduction In Vitro and In Vivo
- 453 Downloads
Adenoviruses are among the most powerful gene delivery systems. Even if they present low potential for oncogenesis, there is still a need for minimizing widespread delivery to avoid deleterious reactions. In this study, we investigated Magnetofection efficiency to concentrate and guide vectors for an improved targeted delivery.
Magnetic nanoparticles formulations were complexed to a replication defective Adenovirus and were used to transduce cells both in vitro and in vivo. A new integrated magnetic procedure for cell sorting and genetic modification (i-MICST) was also investigated.
Magnetic nanoparticles enhanced viral transduction efficiency and protein expression in a dose-dependent manner. They accelerated the transduction kinetics and allowed non-permissive cells infection. Magnetofection greatly improved adenovirus-mediated DNA delivery in vivo and provided a magnetic targeting. The i-MICST results established the efficiency of magnetic nanoparticles assisted viral transduction within cell sorting columns.
The results showed that the combination of Magnetofection and Adenoviruses represents a promising strategy for gene therapy. Recently, a new integrated method to combine clinically approved magnetic cell isolation devices and genetic modification was developed. In this study, we validated that magnetic cell separation and adenoviral transduction can be accomplished in one reliable integrated and safe system.
KEY WORDSAdenoMag adenovirus in vivo transduction magnetic cell sorting magnetofection
ACKNOWLEDGMENTS & DISCLOSURES
This research was supported by the European Union through the following projects: FP6-LIFESCIHEALTH Project “Magselectofection” Contract LSHB-CT-2006-19038; FP6-LIFESCIHEALTH Project “Epicure” Contract LSHM-CT-2006-037315 and FP7 EU-Project: Project “GAMBA” Contract NMP3-SL-2010-245993.
C.S., N.L., F.S. and O.Z. are employed by OZ Biosciences, which manufactures and distributes the AdenoMag and Viro-MICST products.
- 20.Plank C, Zelphati O, Mykhaylyk O. Magnetically enhanced nucleic acid delivery. Ten years of magnetofection-Progress and prospects. Adv Drug Deliv Rev. 2011.Google Scholar
- 25.Payne RP, Kloverpris H, Sacha JB, Brumme Z, Brumme C, Buus S, et al. Efficacious early antiviral activity of HIV Gag- and Pol-specific HLA-B 2705-restricted CD8+ T cells. J Virol;84(20):10543–57.Google Scholar
- 38.Sapet C, Laurent N, Le Gourrierec L, Augier S, Zelphati O. In vitro and in vivo Magnetofection: a move towards gene therapy. Ann Biol Clin (Paris). 2010;68(2):133–42.Google Scholar
- 46.Bowers WJ, Breakefield XO, Sena-Esteves M. Genetic therapy for the nervous system. Hum Mol Genet;20(R1):R28-41.Google Scholar
- 50.Rajagopalan S, Mohler 3rd ER, Lederman RJ, Mendelsohn FO, Saucedo JF, Goldman CK, et al. Regional angiogenesis with vascular endothelial growth factor in peripheral arterial disease: a phase II randomized, double-blind, controlled study of adenoviral delivery of vascular endothelial growth factor 121 in patients with disabling intermittent claudication. Circulation. 2003;108(16):1933–8.PubMedCrossRefGoogle Scholar
- 51.Flotte TR, Zeitlin PL, Reynolds TC, Heald AE, Pedersen P, Beck S, et al. Phase I trial of intranasal and endobronchial administration of a recombinant adeno-associated virus serotype 2 (rAAV2)-CFTR vector in adult cystic fibrosis patients: a two-part clinical study. Hum Gene Ther. 2003;14(11):1079–88.PubMedCrossRefGoogle Scholar
- 59.Jahnke A, Hirschberger J, Fischer C, Brill T, Kostlin R, Plank C, et al. Intra-tumoral gene delivery of feIL-2, feIFN-gamma and feGM-CSF using magnetofection as a neoadjuvant treatment option for feline fibrosarcomas: a phase-I study. J Vet Med A Physiol Pathol Clin Med. 2007;54(10):599–606.PubMedCrossRefGoogle Scholar
- 65.Minang JT, Trivett MT, Barsov EV, Del Prete GQ, Trubey CM, Thomas JA, et al. TCR triggering transcriptionally downregulates CCR5 expression on rhesus macaque CD4(+) T-cells with no measurable effect on susceptibility to SIV infection. Virology 2011.Google Scholar